Reports of Radiotherapy and Oncology

Published by: Kowsar

Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate

Kambiz Novin 1 , Shiva Moghadam 1 , * , Nafiseh Mortazavi 2 , Farnaz Hosseini Kamal 3 , Helaleh Khoshbakht Ahmadi 1 and Ahamd Ameri 1
Authors Information
1 Clinical Oncology Department, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Pathology Department, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Chemical and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden
Article information
  • Reports of Radiotherapy and Oncology: June 28, 2015, 2 (2); e3093
  • Published Online: June 12, 2015
  • Article Type: Research Article
  • Received: May 1, 2015
  • Accepted: May 15, 2015
  • DOI: 10.17795/rro-3093

To Cite: Novin K, Moghadam S, Mortazavi N, Hosseini Kamal F, Khoshbakht Ahmadi H, et al. Cisplatin-Based Chemotherapy Eligibility: Discrepancy Between Serum Creatinine Level and Glomerular Filtration Rate, Rep Radiother Oncol. 2015 ; 2(2):e3093. doi: 10.17795/rro-3093.

Abstract
Copyright © 2015, Iranian Society of Clinical Oncology.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
References
  • 1. Kannapiran M, Nisha D, Madhusudhana Rao A. Underestimation of impaired kidney function with serum creatinine. Indian J Clin Biochem. 2010; 25(4): 380-4[DOI][PubMed]
  • 2. Diamandopoulos A, Goudas P, Arvanitis A. Comparison of estimated creatinine clearance among five formulae (Cockroft-Gault, Jelliffe, Sanaka, simplified 4-variable MDRD and DAF) and the 24hours-urine-collection creatinine clearance. Hippokratia. 2010; 14(2): 98-104[PubMed]
  • 3. Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens. 1999; 17(3): 309-17[PubMed]
  • 4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16(1): 31-41[PubMed]
  • 5. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145(4): 247-54[PubMed]
  • 6. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988; 39: 465-90[DOI][PubMed]
  • 7. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354(23): 2473-83[DOI][PubMed]
  • 8. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem. 1991; 37(5): 695-700[PubMed]
  • 9. Oh MS. HENRY'S Clinical Diagnosis and Management by Laboratory Methods. 2011; : 169-92[DOI]
  • 10. BCCA Protocol Summary for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with Docetaxel,cisplatin and Infusional Fluorouracil.
  • 11. Dahal A, Bellows BK, Sonpavde G, Galsky MD, Agarwal N. Cisplatin-associated nephrotoxicity in clinical trials using serum creatinine (SCr) versus calculated glomerular filtration rate (GFR) as inclusion criterion: A meta-analysis. J Clin. 2013; 31(6)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments